by author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010
|
|
- Tobias Eaton
- 5 years ago
- Views:
Transcription
1 EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 Gunnar Kahlmeter Chairman of EUCAST
2 Terms and acronyms AST Antimicrobial Susceptibility Testing MIC Minimum Inhibitory Concentration EU European Union EUCAST European Committee on Antimicrobial Susceptibility Testing ESCMID The European Society of Clinical Microbiology and Infectious Diseases ECDC The European Centre for Disease prevention and Control EMA (EMEA) The European Medicines Agency CLSI Clinical Laboratory Standards Institute (USA) (formerly NCCLS) SPC Summary of Product Characteristics
3 Formed in 1996 and reorganised in 2001 Financed by ESCMID, EU and ECDC and National Breakpoint Committees (BSAC, CA-SFM, CRG, DIN, NWGA, SRGA). All European countries represented.
4 Breakpoint committees 2001 for determining clinical MIC breakpoints Committee Country Disk test? BSAC United Kingdom Yes CA-SFM France Yes CLSI USA Yes CRG The Netherlands No DIN Germany Yes NWGA Norway No SRGA Sweden Yes
5 Breakpoint committees 2010 for determining clinical MIC breakpoints Committee Country Disk test? EUCAST* Europe Yes CLSI USA Yes *For national breakpoint committees BSAC, CA-SFM, CRG, DIN, NWGA & SRGA
6 EUCAST General Committee All European Countries + ISC/FESCI EUCAST Steering Committee BSAC, CA-SFM, CRG, DIN, NWGA, SRGA And 2 reps from the General Committee* Subcommittees Antifungals Anaerobes Expert Rules *Currently: Estonia and Austria National Breakpoint Committees D, F, N, NL, S, UK, Expert groups
7 Wild type Clinical resistance Clinical resistance Clinical resistance Clinical resistance Susceptible Phenotypically detectable resistance Genetically detectable resistance Resistant
8 Breakpoints may fail in several ways! Fail to predict failure (undercall resistance) CLSI piperacillintazobactam breakpoints in Pseudomonas Fail to predict success (overcall resistance) Penicillin breakpoints in S.pneumoniae in pneumonia Generally fail to be useful (lack of correlation with either success or failure) Erythromycin breakpoints in H.influenzae (dividing a WT population in three SIR-categories)
9 Breakpoints that failed to predict failures! Classical cases. Carbapenem breakpoints in MRSA (70ies) Chloramphenicol breakpoints in H.influenzae (70ies) Cephalosporin breakpoints (CLSI) in Enterobacteriaceae Erythromycin breakpoints in S.pneumoniae Piperacillintazobactam breakpoints in Pseudomonas Vancomycin breakpoints in S.aureus Fluoroquinolone breakpoints in critical (Salmonella) infections.. With few exceptions, all revisions of breakpoints have brought breakpoints down!
10 Tools for determining CLINICAL BREAKPOINTS 1. Dose or doses 2. Target organisms 3. Individual MIC-distributions for target organisms - breakpoints must not divide MIC-distributions of WT target organisms - ECOFFs determined for each species 4. Resistance mechanisms in target organisms 5. Clinical indications 6. Pharmacokinetics (Cmax, AUC, T½, Protein binding, Vd..) 7. Pharmacodynamic properties (peak conc/mic, AUC/MIC, TA, MCs) 8. Clinical outcome (clinical outcome/mic) 9. Epidemiological cutoffs, Pk/Pd-breakpoints and clinical data together determine the CLINICAL BREAKPOINT
11 Setting breakpoints For existing drugs harmonisation of Euopean brekpoints (finalised) review of existing breakpoints Altered indications Change in target organisms New resistance mechanisms New drug in class New clinical experience Change in dosing or administration For new drugs (with EMA)
12 EUCAST and existing antimicrobials Aminoglycosides Carbapenems & aztreonam Cephalosporins iv Cephalosporins oral Fluoroquinolones Glycopetides Macrolides and lincosamides Penicillins Tetracyclines Miscellaneous antimicrobials Antifungal drugs (flu- and voriconzole)
13 Setting breakpoints For existing drugs harmonisation of Euopean brekpoints (finalised) review of existing breakpoints Altered indications Change in target organisms New resistance mechanisms New drug in class New clinical experience Change in dosing or administration For new drugs (with EMA)
14 Review of breakpoints EUCAST Change +/No change - CLSI Change/No change Cephalosporins + + Aztreonam + NE* Carbapenems - + Vanco/Teico +/+ +/NE* Colistin (Pseud) 2 to 4 mg/l NE* * Not Evaluated
15 Setting breakpoints For existing drugs harmonisation of Euopean brekpoints (finalised) review of existing breakpoints Altered indications Change in target organisms New resistance mechanisms New drug in class New clinical experience Change in dosing or administration For new drugs (with EMA)
16 EUCAST - breakpoints for new drugs with EMA* Daptomycin Tigecycline Doripenem Glycopeptides (ongoing) Cefalosporin (withdrawn) Fluoroquinolone (withdrawn) Diaminopyrimidine (withdrawn) Extensions of indications (currently none) *EMA = European Medicines Agency
17 Topicals and less commonly used drugs 1. Mupirocin (Topical) 2. Polymyxin B (Topical) 3. Bacitracin (Topical) 4. Streptomycin (hlr for enterococci) 5. Neomycin (Topical) 6. Sulfamethoxazole (UTI) 7. Cephalothin (expert rules?) 8. Sulfadiazine 9. Spiramycin 10.Nalidixic acid (screening) 11.Cefoperazone 12.Pefloxacin 13.Cefradine 14.Cefamandole 15.Sulfisoxazole 16.Pipemidic acid 17.Kanamycin 18.Ceftizoxime 19.Cefprozil + 45 others
18 Microorganisms to be evaluated for breakpoints Define relevant drugs, breakpoints, methodology and MIC-distributions. Helicobacter spp Campylobacter spp Clostridium difficile Legionella spp Pasteurella multocida Listeria monocytogenes Burkholderia cepacia Corynebacterium spp
19 EUCAST web-pages
20
21
22 EUCAST Rationale Documents Summarize available data on the drug at the time the breakpoint was determined or revised Available on EUCAST website
23
24
25
26
27
28
29
30
31
32
33 Intrinsic resistance EUCAST expert rules v1.0 v2.0 (2010) Exceptional phenotypes Exceptional resistance Exceptional susceptibility Interpretive reading IF - THEN
34 EUCAST and CLSI are different EUCAST Profession together with regulatory authorities Funded by ESCMID, ECDC and national breakpoint committees. Industry consultative role. Decision by consensus. Five meetings per year. EUCAST=EMEA brpt committee. Clinical breakpoints and ECOFFs Rationale for decisions published Documents in public domain and free of charge CLSI Industry, the profession Funded by industry and sales of output. Industry part of decision process Decision by vote. Two meetings per year. CLSI technical standing with FDA. Clinical breakpoints Rationale for decisions not published. Documents for sale
35 Web-links to MIC-distributions Web-links to Zone diameter distributions Web-links to EUCAST Rationale Documents
36 EUCAST disk diffusion
37 NAC National Antimicrobial susceptibility testing Committee
38 Remit: NAC A NAC is a committee which deals with questions related to antimicrobial susceptibility testing at a national level. Membership: representatives of clinical microbiological diagnostic services national experts on susceptibility testing of bacteria (and fungi) representatives of reference clinical microbiology laboratories, government professional organisations/societies, Represntatives of other antibiotic committees Structure Chairperson, scientific secretary, educational officer and representatives of laboratories, societies, reference laboratories (5 6 reps) Funding national level
39 Tasks and objectives NAC Strategy for AST on national level Implementation of breakpoints and methods Quality assurance on a national level Education of laboratory staff and clinical colleagues Liaison and consultation with EUCAST (GC rep) Liaison with groups involved in AMR-surveillance (ECDC, EARSS,.).. Antimicrobial Policies Antimicrobial Resistance Surveillance Antimicrobial Consumption and Policies
40 EUCAST/NABC: France Germany Norway Sweden The Netherlands The UK EUCAST breakpoints and NACs NAC 2010/11: Austria Belgium Denmark Estonia Finland Hungary Ireland Italy Spain Switzerland Discussion: Croatia Greece Israel Poland Russia Turkey Lithuania Latvia Portugal, Poland, Czeck republic, Slovakia,, Slovenia, Serbia, Rumania
41 Thank you!
EUCAST 2010 Why European breakpoints?
EUCAST 2010 Why European breakpoints? Gunnar Kahlmeter Chairman of EUCAST Clinical microbiology Växjö, Sweden gunnar.kahlmeter@ltkronoberg.se Antimicrobial susceptibility testing to predict success and
More informationBSAC antimicrobial susceptibility
BSAC antimicrobial susceptibility testing - from Stokes to European harmonization to world? Derek Brown 23 March 2011 BSAC antimicrobial susceptibility testing ti pre-working Party BSAC meetings from the
More informationCLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014
vs. Olga Perovic, Principal Pathologist, Center for Opportunistic, Tropical and Hospital Infections, Associate Professor at WITS, Saturday, May 24, 2014 A not-for-profit membership organization, the Clinical
More informationESCMID Online Lecture Library. by author
EUCAST and susceptibility testing Europe and beyond Gunnar Kahlmeter EUCAST, ESCMID Antimicrobial susceptibility testing To guide therapy and predict clinical outcome in individual patients (clinical breakpoints)
More informationTowards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)
Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) A report to ISC presented by Paul M. Tulkens representative of
More informationTowards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)
Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and some personal thinking Paul M. Tulkens Representative of
More informationWhat is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown
What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationAMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
More informationAntimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationEuropean Medicines Agency role and experience on antimicrobial resistance
European Medicines Agency role and experience on antimicrobial resistance Regional Training Workshop on Antimicrobial Resistance (AMR) Responding to the global challenge of AMR threats: toward a one health
More informationConsumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
More informationQuelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
More informationA web-based interactive tool to explore antibiotic resistance and consumption via maps and charts
http://resistancemap.cddep.org A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts CDDEP first developed ResistanceMap in 21. The new ResistanceMap now includes
More informationCampylobacter infections in EU/EEA and related AMR
Campylobacter infections in EU/EEA and related AMR Therese Westrell, ECDC EURL Campylobacter workshop, Uppsala, Sweden, 9 October 2018 Zoonoses Zoonotic infections in the EU, 2016 Campylobacteriosis (N
More informationTECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017
TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 www.ecdc.europa.eu ECDC TECHNICAL REPORT External quality
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationEUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)
EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on
More informationAntimicrobial consumption
Antimicrobial consumption Annual Epidemiological Report for 2017 Key facts Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial
More informationAntimicrobial resistance and antimicrobial consumption in Europe
Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November
More informationEFSA s activities on Antimicrobial Resistance
EFSA s activities on Antimicrobial Resistance CRL-AR, Copenhagen 23 April 2009 Annual Workshop of CRL - AR 1 Efsa s Role and Activities on AMR Scientific advices Analyses of data on AR submitted by MSs
More informationEU Health Priorities. Jurate Svarcaite Secretary General PGEU
EU Health Priorities Jurate Svarcaite Secretary General PGEU Members: Professional Bodies & Pharmacists Associations 2016: 33 Countries Austria Belgium Bulgaria Croatia Cyprus Czech Rep Denmark Estonia
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationPrevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationPneumococcus: Antibiotic Resistance in the Region
Pneumococcus: Antibiotic Resistance in the Region Çiğdem Bal Kayacan Istanbul University Istanbul Faculty of Medicine Department of Microbiology & Clinical Microbiology Drug Resistance in S.pneumoniae
More informationThe evolutionary epidemiology of antibiotic resistance evolution
The evolutionary epidemiology of antibiotic resistance evolution François Blanquart, CNRS Stochastic Models for the Inference of Life Evolution CIRB Collège de France Quantitative Evolutionary Microbiology
More informationThe challenge of growing resistance
EXECUTIVE SUMMARY Around 2.4 million people could die in Europe, North America and Australia between 2015-2050 due to superbug infections unless more is done to stem antibiotic resistance. However, three
More informationEuropean poultry industry trends
European poultry industry trends November 5 th 2014, County Monaghan Dr. Aline Veauthier & Prof. Dr. H.-W. Windhorst (WING, University of Vechta) 1 Agenda The European Chicken Meat Market - The global
More informationPrinciples and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013
Principles and Practice of Antimicrobial Susceptibility Testing Microbiology Technical Workshop 25 th September 2013 Scope History Why Perform Antimicrobial Susceptibility Testing? How to Perform an Antimicrobial
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationThe Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in
EFSA Journal 2010; 8(7):1658 SCIENTIFIC REPORT OF EFSA The Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2008 1
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationProf. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons
What are the consequences of rising antibiotic resistance for Sweden? Prof. Otto Cars Chairman The Swedish Strategic programme against antibiotic resistance (Strama) We are overconsuming a global resource
More informationANTIMICROBIAL STEWARDSHIP
ANTIMICROBIAL STEWARDSHIP Australian Pig Veterinarians Annual Conference 11-12 September, 2017 Stephen Page Advanced Veterinary Therapeutics swp@advet.com.au OUTLINE Importance of AMR Antimicrobial use
More informationAntimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationMonitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco
Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco licav@food.dtu.dk 1 DTU Food, Technical University of Denmark Outline EURL-AR
More informationAntibiotic resistance: the rise of the superbugs
Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection
More informationIMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE
IMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE Robert P. Rennie Professor Emeritus Laboratory Medicine and Pathology University
More informationHealth Service Executive Parkgate St. Business Centre, Dublin 8 Tel:
Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationHow do people obtain antibiotics in European countries: an overview
How do people obtain antibiotics in European countries: an overview Dominique L. Monnet, Programme Coordinator Senior Expert, Scientific Advice Unit & the National Antimicrobial Resistance Focal Points
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationOptimising treatment based on PK/PD principles
Optimising treatment based on PK/PD principles Paul M. Tulkens Cellular and Molecular Pharmacology & Center for Clinical Pharmacy Louvain Drug Research Institute Catholic University of Louvain Brussels,
More informationAntibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines
Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines Report and Qualitative Risk Assessment by the Committee for Veterinary Medicinal Products Annex III Surveillance
More informationAntimicrobial consumption
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Antimicrobial consumption Key facts Twenty-nine countries, including 27 EU Member States and two EEA countries (Iceland and Norway) reported data
More informationECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials
ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials P.-A. Belœil (EFSA) and D. Monnet (ECDC) One Health Network on Antimicrobial Resistance
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More informationMain objectives of the EURL EQAS s
EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)
More informationFrank Møller Aarestrup
Danish Veterinary Laboratory Bacterial populations and resistance development: Intestinal tract of meat animals Frank Møller Aarestrup 12 Antibiotic production 10 Mill. Kg 8 6 4 2 0 50 52 54 56 58 60 62
More informationrates adjusted for age, sex, infection subclass, and type of antibiotic treatment used) by British Medical Journal Publishing Group
Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis Craig J Currie BMJ 2014;349:g5493 23 September 2014 More than one in 10 initial antibiotic monotherapies
More informationPractical approach to Antimicrobial susceptibility testing (AST) and quality control
Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,
More informationThe European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in
EFSA Journal 2014;12(3):3590 SCIENTIFIC REPORT OF EFSA AND ECDC The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2012 1
More informationShould we test Clostridium difficile for antimicrobial resistance? by author
Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first
More informationWHO global and regional activities on AMR and collaboration with partner organisations
WHO global and regional activities on AMR and collaboration with partner organisations Dr Danilo Lo Fo Wong Programme Manager for Control of Antimicrobial Resistance Building the AMR momentum 2011 WHO/Europe
More informationAntimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries
Antimicrobial Resistance Tackling the Burden in the European Union Briefing note for EU/EEA countries Antimicrobial Resistance Tackling the Burden in the European Union Contents Key messages 03 Use of
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationSurveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens
Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens Dr Pat Mitchell R & I Manager Production Stewardship APL CDC Conference, Melbourne June 2017 Dr Kylie Hewson
More informationWHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis
WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis Aim: to estimate the burden of MDROs isolated among inpatients in a wide range of health-care
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationGlobal animal production perspectives and correlated use of antimicrobial agents
Global animal production perspectives and correlated use of antimicrobial agents Barbara Freischem Executive Director, International Federation for Animal Health (IFAH) General Overview Presentation overview
More informationHSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland
Surveillance of Antimicrobial Consumption in Ireland Ajay Oza A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance (1998-1999) Bronzwaer et al 2002 Emerging Infectious
More informationEducating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges
Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association
More informationSCIENTIFIC REPORT. Analysis of the baseline survey on the prevalence of Salmonella in turkey flocks, in the EU,
The EFSA Journal / EFSA Scientific Report (28) 198, 1-224 SCIENTIFIC REPORT Analysis of the baseline survey on the prevalence of Salmonella in turkey flocks, in the EU, 26-27 Part B: factors related to
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationMRSA in the United Kingdom status quo and future developments
MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationStop overuse of antibiotics in humans rational use
Stop overuse of antibiotics in humans rational use Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections (ARHAI) European Centre
More informationWhy we perform susceptibility testing
22 nd June 2015 Why we perform susceptibility testing Robin A Howe Antimicrobial use in Primary Care Why do we perform AST? Clinical Clinical Prediction Prediction of of Efficacy Efficacy Why do we perform
More informationThe threat of multidrug-resistant microorganisms and how to deal with it in Europe
The threat of multidrug-resistant microorganisms and how to deal with it in Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationPenicillins - EUCAST clinical MIC breakpoints (version 1.3)
EUCAST clinical MIC breakpoints - penicillins Penicillins - EUCAST clinical MIC breakpoints 2009-04-19 (version 1.3) Penicillins Click on antibiotic name to see wild type MIC distributions. Enterobacteriaceae
More informationAn agency of the European Union
An agency of the European Union Human medicines in 23 Research and development 473 overall number of scientific advice and protocol assistance requests received in 23
More informationAnnual report of the Scientific Network on BSE-TSE 2015
TECHNICAL REPORT APPROVED: 10 December 2015 PUBLISHED: 11 December 2015 Annual report of the Scientific Network on BSE-TSE 2015 Abstract European Food Safety Authority The EFSA Scientific Network on bovine
More informationECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013 What is the European Union? 27 Member States 24 official languages
More informationFoodborne Zoonotic Parasites
Foodborne Zoonotic Parasites Lucy J. Robertson, Norwegian University of Life Sciences, Oslo, Norway Norwegian University of Life Sciences 1 Foodborne pathogens increasing importance?? Increasing awareness
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationThe European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015
SCIENTIFIC REPORT ADOPTED: 26 January 2017 doi: 10.2903/j.efsa.2017.4694 The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in
More informationThis document is available on the English-language website of the Banque de France
JANUARY 7 This document is available on the English-language website of the www.banque-france.fr Countries ISO code Date of entry into the euro area Fixed euro conversion rates France FR //999.97 Germany
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationChart showing the average height of males and females in various world countries.
Chart showing the average height of males and females in various world countries. Country/Region Average male height Average female height Sampled Age Range Albania 174.0 cm (5 ft 8 1/2 in) 161.8 cm (5
More informationEFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA
EFSA s activities on Antimicrobial resistance in the food chain Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA EFSA IS The reference body for risk assessment of food and feed in the European Union. Its
More informationProject Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms
Project Summary Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms Principal Investigators: Mindy Brashears, Ph.D., Texas Tech University Guy
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More information1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS
PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...
More informationEFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.
EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication. Dr. Ernesto Liebana BIOHAZ Team Leader European Food Safety Authority (EFSA) EFSA
More informationPunto di vista dell EFSA e raccolta dati Valentina Rizzi Unit on Biological Monitoring (BIOMO)
Committed since 2002 to ensuring that Europe s food is safe Punto di vista dell EFSA e raccolta dati Valentina Rizzi Unit on Biological Monitoring (BIOMO) Corso di formazione Gestione per il contenimento
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationEUCAST 2016/17 and what to do when there are no breakpoints and if the UK should exit EU
EUCAST 2016/17 and what to do when there are no breakpoints and if the UK should exit EU Gunnar Kahlmeter What is new in EUCAST? New organisms breakpoints 2016 Breakpoints for exisiting agents breakpoints
More informationInitiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More information